Intuitive Surgical (ISRG)
Intuitive Surgical's (<a href=http://www.zacks.com/stock/quote/isrg>ISRG</a>) story is improving. A new product was developed as an upgrade to its da Vinci Surgical System. Furthermore, the company enjoys a virtual monopoly in robotic surgery without direct competition. <p> The company's razor/razor blade business model ensures recurring revenues even during difficult times. In the third quarter, earnings of $1.64 per share were higher than the Zacks Consensus Estimate of $1.45. Revenue growth was witnessed across all the segments. <p> We believe the company will continue leveraging its monopoly position in the industry. We reiterate our Outperform recommendation with a target price of $329.
December 30, 2009 | Filed Under Stock Picks
Comments
Leave a Reply